LivaNova shares rise 17% after outlook boost and strong first quarter
Updated
Updated · MarketWatch · May 6
LivaNova shares rise 17% after outlook boost and strong first quarter
14 articles · Updated · MarketWatch · May 6
The stock reached $67.17 on Wednesday after the medical-technology company lifted 2026 revenue growth guidance to 7%-8% from 6%-7%.
It also raised adjusted earnings guidance to $4.20-$4.30 a share from $4.15-$4.25 after first-quarter adjusted EPS of 98 cents beat FactSet analysts' 91-cent estimate.
Quarterly revenue rose 14% to $362.3 million, topping Wall Street expectations of $345.7 million, and extending the shares' gain to more than 54% over the past year.
Can LivaNova’s new sleep apnea device convert its impressive revenue growth into sustainable company profits?
As a key competitor exits, can LivaNova's expansion plans secure its dominance in the cardiopulmonary market?